Short answer
Tevogen Bio Holdings Inc. (TVGN) filed an 8-K current report with the SEC on September 16, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). CEO Ryan Saadi granted 8,000,000 restricted shares; CFO Kirti Desai granted 750,000 under the 2024 incentive plan.
Tevogen Bio Holdings Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- CEO Ryan Saadi granted 8,000,000 restricted shares; CFO Kirti Desai granted 750,000 under the 2024 incentive plan
- Vesting requires $1.0 billion aggregate revenue by September 30, 2031, tying compensation to a major long-term growth milestone
- Executives retain voting rights before vesting, increasing insider influence over shareholder decisions
- Post-grant ownership: Saadi 74.4% and Desai 6.3% of 15,736,540 outstanding common shares
- Unvested awards face forfeiture upon missed target, termination, certain change-in-control events, transfers, or detrimental conduct
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Tevogen Bio Holdings Inc. 8-K filings
Get the next TVGN 8-K as it lands
Follow TVGN for push alerts, or ask the research agent what this filing means.